Genotype Patients n= 130 Controls n=189  OR IC (95%)   p Co-dominant model n (%) n (%)     GG* 37 (28.5) 48 (25.4)     GA 71 (54.6) 95 (57.2) 0.96 (0.57-1.64) 0.90 AA 22 (16.9) 46 (24.3) 0.62 (0.31-0.12) 0.15 Dominant model         GG* 37 (28.5) 48 (25.4)     GA + AA 93 (71.5) 141 (74.6) 0.85 (0.51-1.41) 0.54 Recessive model         GG* + GA 108 (83.1) 143 (75.7)     AA 22 (16.9) 46 (24.3) 0.66 (0.35-1.11) 0.11 Allele         G 145 (55.8) 195 (51.0)     A 115 (44.2) 187 (49.0)   0.23 OR: Odds Ratio; CI: Confidence Interval. Categorical variables were compared using the χ2 test

Table 1: Genotype distribution and allele frequencies of the LEP G-2548A polymorphism in control subjects and patients with breast cancer.